Advertisement

Fremdblut sparende Maßnahmen

  • Fabian Spöhr
  • B. W. Böttiger
Chapter
  • 66 Downloads

Zusammenfassung

Die Gabe von Fremdblut im operativen und intensivmedizinischen Bereich gehört zum Aufgabenbereich des Anästhesisten. Sie wird häufig als unumgänglich betrachtet, um die Gewebsoxygenierung eines Patienten zu gewährleisten. Wegen der mit der Fremdbluttransfusion verbundenen Risiken bedarf die Indikationsstellung zur Fremdblutgabe jedoch der kritischen Abwägung von Nutzen und Risiken im Einzelfall. Die unterschiedliche Bewertung dieser Frage hat in der Vergangenheit zu sehr unterschiedlichen Transfusionspraktiken bei der Behandlung der gleichen Kategorie von Patienten geführt.

Fremdblut sparende Maßnahmen versprechen den Nutzen einer ausreichenden Anzahl von Sauerstoffträgern ohne die typischen Nachteile der allogener Bluttransfusion. Dennoch erlaubt nur die genaue Kenntnis dieser Verfahren einen für den Patienten effektiven und risikoarmen Einsatz.

Im Folgenden werden Nutzen und Risiken des Einsatzes von Fremdblut, sowie Maßnahmen zur Verringerung allogener Transfusionen kritisch beleuchtet. Diese Maßnahmen können einerseits im restriktiven Einsatz von Fremdblut, andererseits in spezifischen Fremdblut sparenden Maßnahmen liegen. Darüber hinaus ist eine blutarme Operationstechnik entscheidend für das Einsparen von Fremdbluttransfusionen; dies soll jedoch hier nicht näher erläutert werden.

Literatur

  1. 1.
    American Society of Anesthesiologists Task Force (1996) Practice guidelines for blood component therapy. A report by the American Society of Anesthesiologists Task Force on blood component therapy. Anesthesiology 84:732–747CrossRefGoogle Scholar
  2. 2.
    Bengtsson A, Bengtson JP (1996) Autologous blood transfusion: preoperative blood collection and blood salvage techniques. Acta Anaesthesiol Scand 40:1041–1056PubMedCrossRefGoogle Scholar
  3. 3.
    Blackwell KE, Ross DA, Kapur P, Calcaterra TC (1993) Propofol for maintenance of general anesthesia: a technique to limit blood loss during endoscopic sinus surgery. Am J Otolaryngol 14:262–266PubMedCrossRefGoogle Scholar
  4. 4.
    Blajchman MA (1999) Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse? Transfusion 39:665–670PubMedCrossRefGoogle Scholar
  5. 5.
    Bock M, Müller J, Bach A, Böhrer H, Marti, E, Mot-sch J (1998) Effects of preinduction and intraoperative warming during major laparotomy. Br J Anaesth 80:159–163PubMedCrossRefGoogle Scholar
  6. 6.
    Boylan J F, Klinck JR, Sandler AN, Arellano R, Greig PD, Nierenberg, H, Roger SL, Glynn MF (1996) Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 85:1043–1048PubMedCrossRefGoogle Scholar
  7. 7.
    Bryson GL, Laupacis A, Wells GA (1998) Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis.The International Study of Perioperative Transfusion. Anesth Analg 86:9–15PubMedGoogle Scholar
  8. 8.
    Bundesärztekammer (2001) Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. 2. Aufl. BundesärztekammerGoogle Scholar
  9. 9.
    Capdevila X, Calvet Y, Biboulet P, Biron C, Rubenovitch J, d’Athis F (1998) Aprotinin decreases blood loss and homologous transfusions in patients undergoing major orthopedic surgery. Anesthesiology 88:50–57PubMedCrossRefGoogle Scholar
  10. 10.
    Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, Noveck H, Strom BL (1996) Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348(9034):1055–1060PubMedCrossRefGoogle Scholar
  11. 11.
    Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, Magaziner J, Merlino FE, Bunce G, McClelland B, Duff A, Noveck H (1998) A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture.Transfusion 38:522–529PubMedCrossRefGoogle Scholar
  12. 12.
    Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ (1999) Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med 27:2346–2350PubMedCrossRefGoogle Scholar
  13. 13.
    Dietrich W, Spath P, Zuhlsdorf M, Dalichau H, Kirchhoff PG, Kuppe H, Preiss DU, Mayer G (2001) Anaphylactic reactions to aprotinin reexposure in cardiac surgery: relation to antiaprotinin immunoglobulin G and E antibodies. Anesthesiology 95:64–71CrossRefGoogle Scholar
  14. 14.
    Dilthey G, Dietrich W, Spannagl M, Richter JA (1993) Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. J Cardiothorac Vasc Anesth 7:425–430PubMedCrossRefGoogle Scholar
  15. 15.
    Egli GA, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR (1997) Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth 78:684–689PubMedCrossRefGoogle Scholar
  16. 16.
    Fontana JL, Welborn L, Mongan PD, Sturm P, Martin G, Bunger R (1995) Oxygen consumption and cardiovascular function in children during profound intraoperative normovolemic hemodilution. Anesth Analg 80:219–225PubMedGoogle Scholar
  17. 17.
    Garcia-Huete L, Domenech P, Sabate A, Martinez-Brotons F, Jaurrieta E, Figueras J (1997) The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study. Hepatology 26:1143–1148PubMedCrossRefGoogle Scholar
  18. 18.
    Goodnough LT, Monk TG, Andriole GL (1997) Erythropoietin therapy. N Engl J Med 336:933–938PubMedCrossRefGoogle Scholar
  19. 19.
    Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP (1999) Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 340:438–447PubMedCrossRefGoogle Scholar
  20. 20.
    Habler O, Messmer K (1997) Verfahren zur Reduktion von Fremdbluttransfusionen in der operativen Medizin. Anaesthesist 46:915–926PubMedCrossRefGoogle Scholar
  21. 21.
    Halpern NA, Alicea M, Seabrook B, Spungen A, Greenstein R (1997) Isolyte S, a physiologic multielectrolyte solution, is preferable to normal saline to wash cell saver salvaged blood: conclusions from a prospective, randomized study in a canine model. Crit Care Med 25:2031–2038PubMedCrossRefGoogle Scholar
  22. 22.
    Hansen E, Knuechel R, Altmeppen J, Taeger K (1999) Blood irradiation for intraoperative autotransfusion in cancer surgery: demonstration of efficient elimination of contaminating tumor cells. Transfusion 39:608–615PubMedCrossRefGoogle Scholar
  23. 23.
    Hébert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, Blajchman MA, Schweitzer I, Pagliarello G (1997) Does transfusion practice affect mortality in critically ill patients? Am J Respir Crit Care Med 155:1618–1623PubMedCrossRefGoogle Scholar
  24. 24.
    Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417PubMedCrossRefGoogle Scholar
  25. 25.
    Hébert PC, Blajchman MA, Cook DJ, Yetisir E, Wells G, Marshall J, Schweitzer I (2001) Do blood transfusions improve outcomes related to mechanical ventilation? Chest 119:1850–1857PubMedCrossRefGoogle Scholar
  26. 26.
    Hébert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, Tweeddale M, Pagliarello G, Schweitzer I (2001) Is a low transfusion threshold safe in critically ill patients with cardiovascular disease? CritCare Med 29:227–233CrossRefGoogle Scholar
  27. 27.
    Hogue CW Jr, Goodnough LT, Monk TG (1998) Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion 38:924–931PubMedCrossRefGoogle Scholar
  28. 28.
    Houston F, Foster JD, Chong A, Hunter N, Bostock CJ (2000) Transmission of BSE by blood transfusion in sheep. Lancet 356(9234):999–1000PubMedCrossRefGoogle Scholar
  29. 29.
    Huet C, Salmi LR, Fergusson D, Koopman-van Gemert AW, Rubens F, Laupacis A (1999) A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 89:861–869PubMedCrossRefGoogle Scholar
  30. 30.
    Jensen LS, Grunnet N, Hanberg-Sorensen F, Jorgensen J (1995) Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery. Transfusion 35:719–722PubMedCrossRefGoogle Scholar
  31. 31.
    Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N (1996) Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 348(9031):841–845PubMedCrossRefGoogle Scholar
  32. 32.
    Joh nson RG, Thurer RL, Kruskall MS, Sirois C, Ger-vino EV, Critchlow J, Weintraub RM (1992) Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg 104:307–314PubMedGoogle Scholar
  33. 33.
    Jones RM, Moulton CE, Hardy KJ (1998) Central venous pressure and its effect on blood loss during liver resection Br J Surg 85:1058–1060PubMedCrossRefGoogle Scholar
  34. 34.
    Kleinschmidt S (2001) Hat die kontrollierte Hypotension einen Stellenwert im Rahmen fremdblutsparender Verfahren? Anaesthesist 50 [Suppl 1]:39–42CrossRefGoogle Scholar
  35. 35.
    Kopko PM, Holland PV (1999) Transfusion-related acute lung injury. Br J Haematol 105:322–329PubMedCrossRefGoogle Scholar
  36. 36.
    Kurz A, Sessler Dl, Lenhardt R (1996) Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 334:1209–1215PubMedCrossRefGoogle Scholar
  37. 37.
    Levy JH (1999) Hemostatic agents and their safety. J Cardiothorac Vasc Anesth 13 [Suppl 1]:6–11PubMedGoogle Scholar
  38. 38.
    Nelson AH, Fleisher LA, Rosenbaum SH (1993) Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 21:860–866PubMedCrossRefGoogle Scholar
  39. 39.
    Opelz G, Vanrenterghem Y, Kirste G, Gray DW, Horsburgh T, Lachance JG, Largiader F, Lange H, Vujaklija-Stipanovic K, Alvarez-Grande J, Schott W, Hoyer J, Schnuelle P, Descoeudres C, Ruder H, Wujciak T, Schwarz V (1997) Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 63:964–967PubMedCrossRefGoogle Scholar
  40. 40.
    Popovsky MA (2001) Transfusion and lung injury. Transfus Clin Biol 8:272–277PubMedCrossRefGoogle Scholar
  41. 41.
    Popovsky MA, Whitaker B, Arnold NL(1995) Severe outcomes of allogeneic and autologous blood donation: frequency and characterization.Transfusion 35:734–737PubMedCrossRefGoogle Scholar
  42. 42.
    Porte RJ, Molenaar IQ, Begliomini B, Groenland THN, Januszkiewicz A, Lindgren L, Pa-lareti G, Hermans J, Terpstra OT (2000) Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. Lancet 355:1303–1309PubMedCrossRefGoogle Scholar
  43. 43.
    Price TH, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI (1996) The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial. Transfusion 36(1):29–36PubMedCrossRefGoogle Scholar
  44. 44.
    Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996) The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334:1685–1690PubMedCrossRefGoogle Scholar
  45. 45.
    Sharrock NE, Mineo R, Urquhart B, Salvati EA (1993) The effect of two levels of hypotension on intraoperative blood loss during total hip arthroplasty performed under lumbar epidural anesthesia. Anesth Analg 76:580–584PubMedGoogle Scholar
  46. 46.
    Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, Ambruso DR (1998) Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 101 (7):1458–1467PubMedCrossRefGoogle Scholar
  47. 47.
    Singbartl G, Schleinzer W (1999) Kostenanalyse autologer Transfusionsverfahren — eine Untersuchung bei 5.017 Patienten. Anasthesiol Inten-sivmed Notfallmed Schmerzther 34:350–358CrossRefGoogle Scholar
  48. 48.
    Sowade O, Warnke H, Scigalla P, Sowade B, Franke W, Messinger D, Gross J (1997) Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 89:411–418PubMedGoogle Scholar
  49. 49.
    Spahn DR, Casutt M (2000) Eliminating blood transfusions: new aspects and perspectives. Anesthesiology 93:242–255PubMedCrossRefGoogle Scholar
  50. 50.
    Spahn DR, Casutt M (2001) Eliminating blood transfusions: What about hypotensive anesthesia? Anesthesiology 94:542–543CrossRefGoogle Scholar
  51. 51.
    Spahn DR, Schmid ER, Seifert B, Pasch T (1996) Hemodilution tolerance in patients with coronary artery disease who are receiving chronic beta-adrenergic blocker therapy. Anesth Analg 82:687–694PubMedGoogle Scholar
  52. 52.
    Spahn DR, Schanz U, Pasch T (1998) Perioperative Transfusionskriterien. Anaesthesist 47:1011–1020PubMedCrossRefGoogle Scholar
  53. 53.
    Spahn DR, Willimann PFX, Faithfull NS (2001) Wirksamkeit der augmentierten akuten normovolämen Hämodilution (A-ANH™). Anaesthesist 50 [Suppl 1]:49–54CrossRefGoogle Scholar
  54. 54.
    Spiess BD, Ley C, Body SC, Siegel LC, Stover EP, Maddi R, D’Ambra M, Jain U, Liu F, Herskowitz A, Mangano DT, Levin J (1998) Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Thorac Cardiovasc Surg 116:460–467PubMedCrossRefGoogle Scholar
  55. 55.
    Stover EP, Siegel LC, Parks R, Levin J, Body SC, Maddi R, D’Ambra MN, Mangano DT, Spiess BD (1998) Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology 88:327–333Google Scholar
  56. 56.
    Tuman KJ, McCarthy RJ, O’Connor CJ, McCarthy WE, Ivankovich AD (1996) Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery. Anesth Analg 83:1178–1184PubMedGoogle Scholar
  57. 57.
    Vamvakas EC (1996) Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion 36:175–186PubMedCrossRefGoogle Scholar
  58. 58.
    Vamvakas EC, Carven JH (1998) Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 122:145–151PubMedGoogle Scholar
  59. 59.
    Viele MK, Weiskopf RB (1994) What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah’s Witnesses. Transfusion 34:396–401PubMedCrossRefGoogle Scholar
  60. 60.
    Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M, Leung JM, Fisher DM, Murray WR, Toy P, Moore MA (1998) Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279:217–221PubMedCrossRefGoogle Scholar
  61. 61.
    Weiskopf RB, Kramer JH, Viele M, Neumann M, Feiner JR, Watson JJ, Hopf HW, Toy P (2000) Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 92:1646–1652PubMedCrossRefGoogle Scholar
  62. 62.
    Weite M (2001) Gibt es einen „kritischen Hämatokrit“? Anaesthesist 50 [Suppl 1]:2–8Google Scholar
  63. 63.
    Westenfelder C, Baranowski RL (2000) Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney 58:647–657CrossRefGoogle Scholar
  64. 64.
    Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, Skacel P, Barbara JA (1999) Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 319(7201):16–19PubMedCrossRefGoogle Scholar
  65. 65.
    Wolff M (2001) Erythropoietin — eine Alternative zur Fremdbluttransfusion? Anaesthesist 50 [Suppl 1]:54–58CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Fabian Spöhr
    • 1
  • B. W. Böttiger
    • 2
  1. 1.Klinik für AnaesthesiologieUniversitätsklinik HeidelbergHeidelbergDeutschland
  2. 2.Klinik für AnaesthesiologieUniversitätsklinikum HeidelbergDeutschland

Personalised recommendations